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Background: Oropharyngeal cancer is frequently associated with human papilloma virus, that also represents a
strong prognostic factor. Local relaps and treatment-related complications are frequent, whereas distant metastases
occur in about 25% of patients.
Case presentation: A 49 years-old male presented with a loco-regionally advanced oropharyngeal squamous cell
carcinoma and was treated with concomitant chemoradiation. A complete clinical and pathological response was
achieved, but the occurrence of necrotising tracheo-esophagitis, with tracheo-mediastino-pleural fistula formation,
further complicated the subsequent clinical course. The patient died suddenly. Autopsy revealed multiple myocardial
and epicardial metastases from oropharyngeal squamous cell carcinoma.
Conclusions: Even in case of a transient complete local response, the potential occurrence of severe complications
and distant metastases, although infrequent, should be considered. Cardiac metastases are frequently underestimated,
as they are often asymptomatic, but may lead to sudden death. Further efforts are needed to improve diagnosis and
therapy in this setting.
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Increasing oropharyngeal cancer incidence has been
observed in numerous developed nations over the past
few decades, though with marked difference between
countries. It has been extensively demonstrated that
alcohol intake and smoke are risk factors for head and
neck cancer (HNC) development; recently, human
papilloma virus (HPV), particularly HPV-16 subtype,
was shown to be etiologically related to oropharyngeal
tumors [1, 2].
In addition, a fair number of studies demonstrated the
prognostic relevance of HPV, with a strikingly better
prognosis and improved responsiveness to chemotherapy* Correspondence: daris.ferrari@asst-santipaolocarlo.it
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Head and neck cancer tends to recur loco-regionally,
and distant metastases are found in less than 30% of
patients [4–7]. Common sites of distant metastases are
lungs and liver, less frequently the central nervous
system. Cardiac metastases from HNC are extremely
rare [8, 9] and the few cases reported in literature are
mainly found in patients affected by tongue cancer [10, 11].
Metastases to the heart and pericardium are much more
common than primary cardiac tumors, originating in most
cases from a carcinoma of the lung [12].The autoptic
frequency of cardiac metastases varies from 0.7% to 3.5% in
the general population, but may increase to 9.1% in patients
with known malignancies [13–16]. The probability of
cardiac involvement depends on the anatomy of the
primary site, disease stage, intrinsic tumor and host biology.le is distributed under the terms of the Creative Commons Attribution 4.0
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cancer (36-39% of cardiac metastases), breast cancer
(10-12%), leukemias (10-21%), gastric, renal and pancreatic
carcinoma, mesothelioma and melanoma [17–19]. Since
cardiac metastases are usually clinically silent, they are fre-
quently unrecognized and diagnosed only post-mortem.
Case presentation
A 49-year-old male was admitted to our hospital in
November 2012, with a two-month history of a sore
throat and difficulties in swallowing. The oropharyngeal
inspection revealed the presence of an ulcerated mass of
the right tonsil extending to the base of the tongue, to
the epiglottis and to the right pyriform sinus. In
addition, bilateral neck lymphadenopaties were palpable.
A biopsy was performed and an HPV- negative squa-
mous cell oropharyngeal carcinoma was diagnosed. The
patient was a heavy smoker (20 packs/year) but denied
alcohol intake. Head and neck computed tomography
(CT) scan and whole body fluorodeoxyglucose positron
emission tomography/computed tomography (FDG
PET/CT) scan confirmed the presence of tumor in the
right tonsil area with bilateral lymph nodes involvement
in levels I-III. The largest nodes measured 2-4 cm in
maximum diameter. No distant metastases were found.
The TNM clinical stage was cT3N2c. Following a multi-
disciplinary discussion, the patient was judged suitable
for concomitant chemoradiotherapy (CRT) and under-
went protective tracheostomy; then, from April to May
2013, he was treated with a combination of intensity-
modulated radiation therapy (IMRT) for a 70 Gy total
dose, and weekly cisplatin for a total dose of 280 mg/m2.
The course of treatment was poorly tolerated, due to
hematologic toxicity (grade 2 neutropenia) and grade 4
oropharyngeal mucositis, eliciting severe pain and
requiring the placement of a percutaneous endoscopic
gastrostomy (PEG) feeding tube. One month after the
end of concomitant CRT, the patient’s clinical conditions
slowly improved.
The CT scan performed at the end of treatment was
negative, and a right tonsil biopsy did not reveal any
residual cancer cell.
In July 2013, the patient was hospitalized because of the
sudden onset of dysphagia, oral pain and extensive oral
mycosis. Fiberoptic endoscopy revealed erosions and
ulcerations of the tracheal, hypopharyngeal and esopha-
geal mucosa, with fungal colonization. Biopsies confirmed
the presence of Candida species hyphae and the absence
of cancer cells, suggesting the diagnosis of a post-radiation
tracheo-esophagitis with fungal colonization.
A few days later the patient, still in treatment with
analgesic and antifungal drugs and fed through the PEG,
reported a stabbing right hemithoracic pain. A plain
chest X-ray showed the occurrence of a spontaneouspyo-pneumothorax that was treated by pleural purulent
fluid drainage and broad-spectrum antibiotics. During
the following days, as a persistent discharge of dark
purulent fluid from the pleural drainage was noted,
enteral nutrition reflux from the stomach to the esopha-
gus, and then along the upper airways to the mediasti-
num and the pleural cavity, was suspected, possibly due
to the formation of a tracheo-mediastino-pleural fistula.
The diagnosis was confirmed by a CT scan (Fig. 1) and
the fistula was treated with the endoscopic insertion of a
silicone stent.
In October 2013, a total-body CT scan was performed;
it showed no evidence of malignant disease and the reso-
lution of the fistula. Two months later, the patient was
urgently hospitalized for loss of consciousness secondary
to hypotension. Anemia (hemoglobin 8 g/dL), probably
caused by a minor oropharyngeal bleeding from the tra-
cheostoma, was observed in blood tests. A thoracic CT
scan, the electrocardiogram and a two-dimensional echo-
cardiogram (ECHO) revealed normal findings with the
exception of the presence of sinus tachycardia. The patient
died suddenly two days after hospitalization.
The autopsy revealed sparse tumor cells in the oropha-
ryngeal and tracheal mucosa, a minimal residual tracheo-
esophageal fistula, and a large number of epicardial and
myocardial metastases from oropharyngeal squamous cell
carcinoma (Figs. 2, 3 and 4).
Conclusions
Patients affected by oropharyngeal cancer have a slightly
better prognosis compared to different sites HNC patients,
but severe clinical complications, either due to the tumor
itself or to loco-regional and systemic therapy, can seriously
compromise survival and quality of life. The poor prognosis
in our case might be influenced by the negativity of HPV
status and by the presence of well- known risk factors such
as heavy smoking, implying a more aggressive disease [3].
However such a series of events is unusual in oropharyn-
geal cancer, particularly when loco-regional control of the
tumor has been achieved.
In our case a tracheo-mediastino-pleural fistula forma-
tion unexpectedly altered the course of the disease after
concomitant CRT. Documented complications of HNC
surgery are mainly pharyngocutaneous fistulae [20].
Tracheo-pleural fistulae are rare consequences of lung
surgery; esophago-pleural fistulae have been reported as
post-surgical complications in a case of peptic ulcer
perforation, in variceal sclerotherapy, or secondary to
infections, usually tuberculosis or mycosis [21–24].
To our knowledge, this is the first report of tracheo-
mediastino-pleural fistula occurrence in a patient treated
with concomitant CRT for HNC. In our case, the occur-
rence of the fistula was probably due to a combination
of tumor spread, Candida mycosis, and inflammatory
Fig. 2 Transversal section of the trachea with evidence of wall disruption
Fig. 1 Contrast-enhanced CT-scan showing an air-filled communication between trachea and mediastinum
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Fig. 3 Sections of the hearth at ventricular level, with evidence of metastases at the interventricular septum and the walls of the right and the
left ventricle
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tracheo-pleural fistula has been reported as a conse-
quence of chemoradiation and bevacizumab therapy in
non-small cell lung cancer; it was successfully treated by
the endoscopic insertion of a silicone stent covered by a
metal sheath, as in our case [25].
Although the endoscopic treatment of a fistula is feas-
ible and often successful, cardiac dissemination of HNC
is almost invariably fatal, leading sometimes to sudden
death. In our case the occurrence of cardiac metastasesFig. 4 Left: low power picture of the wall of left ventricle with evidence of mfurther complicated the patient’s clinical course and
probably was the cause of his death.
Cardiac metastases are rarely diagnosed ante mortem
as they are frequently asymptomatic, but they are found
in up to 24% of autopsied patients, mainly affected by
tongue cancer [26]. Head neck cancer has limited pro-
pensity to give rise to distant metastases, and only spor-
adic cases of cardiac involvement have been reported,
particularly in advanced stage [27–30], although it has
been occasionally observed also in the absence of localetastatic infiltration (Hematoxylin & Eosin, 4X). Right: the same field at 10X
Ferrari et al. Cancers of the Head & Neck  (2016) 1:16 Page 5 of 6recurrence [31]. Metastatic spread may be due to dis-
semination in the bloodstream or in the lymphatic
system, or to intracavitary diffusion through the inferior
vena cava or pulmonary veins [18].
Cardiac metastases cause non-specific symptoms that
depends on the size and location of the metastases,
mimicking a myocardial infarction, or presenting with
ventricular tachycardia, pericardial effusion and cardio-
genic shock [27–29, 32, 33]. However, cardiac metastases
do not generally lead to clinical findings at an early stage
and may be diagnosed, if suspected, by ECHO and cardiac
Magnetic Resonance (MR) or CT scan [34–36]. In our
case the ECHO was negative for metastases shortly before
the onset of the terminal symptoms leading to sudden
death. An FDG PET/CT scan was not repeated, as a con-
sequence of the absence of metastases on CT scan. It
would be of interest to evaluate the presence of increased
FDG activity in the form of cardiac deposits, even in case
of negative CT, but the rapid and fatal course in our case
prevented further clinical evaluations. Cardiac MR is a val-
idated tool for tissue characterization of cardiac masses,
but prospective trials with the aim of studying the prog-
nostic implications of cardiac metastases among patients
with systemic disease are lacking [37].
The treatment of cardiac metastases is generally inef-
fective and cardiac dissemination is almost invariably
fatal, as previously reported [30, 33, 38].
The rare complications reported in this case
highlight the need to carefully monitor the clinical
evolution and the onset of new symptoms in all
patients affected by HNC.
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